Than et al. reported that in a study of 90 Stage II CRC patients classified by tumor CFTR expression, 3-year disease-free survival (DFS) in the quartile of patients with lowest CFTR expression was 30% lower than in the remaining patients with higher CFTR expression [5]. Here, CFTR is linked to colorectal carcinoma.